Participants in phase 1 oncology research trials: are they vulnerable?

Archives of Internal Medicine
Justine SeidenfeldChristine Grady

Abstract

Phase 1 oncology trials involve risk and offer a relatively low prospect of benefit to participants. Some claim that participants constitute a vulnerable population requiring special protections. We undertook this study to determine whether phase 1 oncology trial participants have demographic and health status characteristics of a vulnerable population. We reviewed participant demographic and health status data from phase 1 trials sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute that began between 1991 and 2002 and from 11 previously published studies. Main outcome measures were median age, sex, race/ethnicity, performance status, previous therapy, educational achievement level, and health insurance coverage. Almost 10 000 participants in trials sponsored by the Cancer Therapy Evaluation Program had a median age of 57 years, 90% self-identified as white, 93% had near-normal performance status, 85% had some form of health insurance, and 92% had been previously treated for cancer; 20 000 individuals from published studies had comparable profiles. The demographic and health status characteristics of phase 1 oncology trial participants are not those of a conventional vulnerable population and sugg...Continue Reading

Citations

Mar 1, 2014·Journal of Genetic Counseling·Jessica N EverettVictoria M Raymond
Dec 10, 2009·Investigational New Drugs·Afshin DowlatiPingfu Fu
Feb 28, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Rebecca Dresser
May 13, 2014·Journal of Pain & Palliative Care Pharmacotherapy·Alex Dubov
Nov 10, 2010·Oncology Nursing Forum·Barbara A Biedrzycki
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Shivaani KummarUNKNOWN Task Force on Methodology for the Development of Innovative Cancer Therapies (MDICT)
Sep 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan Kimmelman
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David J StewartRazelle Kurzrock
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hendrik-Tobias ArkenauStan Kaye
Feb 6, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Maurie Markman
Jun 10, 2008·The Cancer Journal·Shivaani KummarJames H Doroshow
Feb 28, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Christine Grady
Jun 24, 2014·Cancer Control : Journal of the Moffitt Cancer Center·Amit Mahipal, Danny Nguyen
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emily AbdolerDavid Wendler
Jun 4, 2021·Qualitative Health Research·Kaitlyn JaffeLindsey Richardson
Jun 13, 2021·Sociology of Health & Illness·Kaitlyn JaffeLindsey Richardson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Thomas G RobertsJeffrey W Clark
The New England Journal of Medicine
Elizabeth HorstmannChristine Grady
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Steven Joffe, Franklin G Miller
Annals of Oncology : Official Journal of the European Society for Medical Oncology
A ItalianoJ-C Soria
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Hendrik-Tobias ArkenauStan Kaye
© 2021 Meta ULC. All rights reserved